 |
|
PalindromX secures £100,000
PalindromX, the developer of a patented technology that facilitates more accurate diagnosis by improving the performance of conventional blood tests, has secured a six-figure investment to continue its proof of concept work.
The company raised £100,000 from Merseyside Special Investment Fund’s (MSIF) Liverpool Ventures Seed Fund. The proceeds will be used to take the company’s analytical methodology to the next phase of development where its viability and potential market demand are assessed.
MSIF was advised on the terms of its investment by Weightmans, led by partner and head of corporate John Schorah, assistant solicitor Lynne Rathbone and associate Sean Crotty.
Schorah said Weightmans has worked with MSIF on several of its investments. “On this occasion, it provided funding to PalindromX so as to assist with its valuable research and development of improved sensitivity for immunoassay techniques.”
Other M&A Deals
- British team buys TelecomFM Oct 24 2008
- Resaca returns to Texas
with AIM cash Jul 17 2008 - Melorio to buy Zenos duo Nov 17 2008
- Ultra’s Weed Instrument deal Nov 13 2008
Special Offers
- 2008 AIM Guide: Jul 17 2007
- Growth Company Investor Magazine: Jul 17 2007
- Cash Shells 2007 - Research report Jul 17 2007
- Venture Capital Trusts Jul 04 2007
M&A News
- Highcross buys Trehaven’s Westport Land Nov 21 2008
- Hertford cashes in on Cheque Exchange Nov 20 2008
- Talbot Hughes McKillop’s Kroll MBO Nov 20 2008
- Cabinet member calls for more VC Nov 19 2008
- United Drug takes The Specials Lab medicine Nov 19 2008
M & A Events
- Quoted Company Awards 2009 28th January
- The Canaccord Adams Media Magnate Awards 26th March
- Rosenblatt New Energy Awards 2009 27th February
- M&A Expanding Internationally 2008 27th November
- M&A Awards 2009 18th February
Business Diary
- M&A Expanding internationally 27th November
- Rosenblatt New Energy Awards 2009 25th February